Reference
Tarride J-E, et al. A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients. ClinicoEconomics and Outcomes Research 11: 477-486, 29 Jul 2019. Available from: URL: https://doi.org/10.2147/CEOR.S208107
Rights and permissions
About this article
Cite this article
TAVI with SAPIEN 3 cost effective vs surgery for aortic stenosis. PharmacoEcon Outcomes News 834, 34 (2019). https://doi.org/10.1007/s40274-019-6134-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6134-9